阿吉奧斯製藥公司
DE ˙ DB ˙ US00847X1046
€23.40 ↑0.80 (3.54%)
2026-06-04
分享價格
SecurityDE:8AP / Agios Pharmaceuticals, Inc.
InstitutionJanus Henderson Group Plc
Latest Disclosed Ownership23,797 shares
Latest Disclosed Value $ 804,696
Janus Henderson Group Plc ownership in 8AP / Agios Pharmaceuticals, Inc.

On May 18, 2026 - Janus Henderson Group Plc filed a 13F-HR/A form disclosing ownership of 23,797 shares of Agios Pharmaceuticals, Inc. (DE:8AP) valued at $613,963 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 23,797 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $556,850 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 23,797 0 0.00 805 24.07 0.0001
2026-05-15 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 23,797 0 0.00 805 24.07 0.0001
2026-02-17 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 23,797 0 0.00 648 -32.15 0.0003
2025-11-14 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 23,797 0 0.00 955 20.89 0.0004
2025-08-14 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 23,797 0 0.00 791 9.57 0.0004
2025-05-15 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 23,797 0 0.00 721 -7.68 0.0004
2025-02-14 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 23,797 -2,100 -8.11 782 -32.03 0.0004
2024-11-14 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 25,897 0 0.00 1,150 2.96 0.0006
2024-08-14 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 25,897 -3,684 -12.45 1,117 29.17 0.0006
2024-05-15 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 29,581 7 0.02 864 31.31 0.0005
2024-02-14 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 29,574 -41 -0.14 659 -10.11 0.0004
2023-11-14 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 29,615 3 0.01 733 -12.75 0.0005
2023-08-14 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 29,612 -35 -0.12 839 23.38 0.0005
2023-05-15 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 29,647 21,058 245.17 681 182.16 0.0004
2023-02-14 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 8,589 0 0.00 241 -0.82 0.0002
2022-11-14 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 8,589 8,589 243 0.0002
2022-08-15 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -8,584 -100.00 0 -100.00
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 8,584 -4,110 -32.38 250 -40.19 0.0001
2022-02-14 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 12,694 6,374 100.85 418 43.15 0.0002
2021-11-16 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 6,320 6,320 292 0.0001
2019-02-06 2018-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -24,800 -100.00 0 -100.00
2018-11-09 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 24,800 -7,600 -23.46 1,913 -29.90 0.0010
2018-08-10 2018-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 32,400 7,400 29.60 2,729 33.45 0.0016
2018-05-14 2018-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 25,000 -460,239 -94.85 2,045 -92.63 0.0012
2018-03-12 2017-12-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 485,239 96,703 24.89 27,741 6.96 0.0171
2018-02-09 2017-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 485,239 96,703 27,741
2017-11-14 2017-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 388,536 -8,418 -2.12 25,935 26.99 0.0166
2017-08-17 2017-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 396,954 396,954 20,423 0.0139
2017-08-14 2017-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 396,954 20,423
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.